Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin. She was speaking just ...

Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates ...

Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates ...

Kamala Harris and Donald Trump are both pledging to make health care more affordable in the U.S., but have largely different ...

INSULIN LITIGATION DEEP-DIVE — As Congress ... in a New Jersey district court against the three major pharmacy middlemen — CVS Caremark, Express Scripts and OptumRx — and three insulin ...

The price of insulin has been a major flashpoint ... Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates with manufacturers ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

The agency said they created a "perverse drug rebate system" that artificially inflates the price of insulin. Each company denied the allegations. The lawsuit followed a scathing FTC report in ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...